サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1781458

脂質ナノ粒子原料の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Lipid Nanoparticle Raw Materials Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 151 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.67円
脂質ナノ粒子原料の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年08月01日
発行: Value Market Research
ページ情報: 英文 151 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脂質ナノ粒子原料の世界市場規模は、2024年の2億5,847万米ドルから2033年には4億3,079万米ドルに成長し、2026年から2033年の予測期間中に5.84%の堅調なCAGRを示すと予測されます。

脂質ナノ粒子原料市場は、製薬業界やバイオテクノロジー業界で高度なドラッグデリバリーシステムに対する需要が高まり続けていることから、大きな成長が見込まれています。脂質ナノ粒子（LNP）は、細胞への取り込みを促進しながら、高感度分子をカプセル化して保護する能力があるため、mRNAワクチンや遺伝子治療を含む治療薬を送達する有望な技術として浮上しています。革新的なドラッグデリバリーソリューションへの世界の注目が高まるにつれ、医薬品の有効性と安全性を高める高品質の材料へのニーズが高まり、脂質ナノ粒子原料市場は大幅に拡大すると予想されます。

さらに、個別化医療と標的療法が重視されるようになり、研究開発者が患者の特定のニーズを満たすオーダーメイドのドラッグデリバリーシステムを開発しようとしているため、脂質ナノ粒子原料市場に影響を与えています。脂質ナノ粒子の汎用性により、さまざまな治療薬を組み込むことができるため、腫瘍学から希少疾患まで幅広い用途に適しています。市場が進化するにつれ、技術革新とカスタマイズへの注目が脂質ナノ粒子原料セクターの成長を促進すると思われます。

さらに、eコマースとデジタルマーケティングの台頭が脂質ナノ粒子原料市場に変革をもたらし、メーカーに消費者と研究者にリーチする新たな手段を提供しています。オンラインプラットフォームにより、サプライヤーは製品を展示し、世界中の視聴者とつながることができ、市場の成長を促進しています。脂質ナノ粒子原料の需要が拡大し続ける中、品質、革新性、顧客エンゲージメントを優先するメーカーは、成功に向けて有利な立場にあると思われます。有効性、安全性、カスタマイズに重点を置く脂質ナノ粒子原料市場の将来は有望であり、ドラッグデリバリーのソリューション強化への道を開きます。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場力学：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 脂質ナノ粒子原料- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 脂質ナノ粒子原料の世界市場分析：用途別

  • 概要： 用途別
  • 用途別過去・予測データ分
  • 治療薬
  • 調査

第6章 脂質ナノ粒子原料の世界市場分析： 製品別

  • 概要：製品別
  • 製品別過去・予測データ分析
  • イオン化可能脂質
  • 試薬
  • その他の原料

第7章 脂質ナノ粒子原料の世界市場分析：疾患適応症別

  • 概要：疾患適応別
  • 疾患適応別過去・予測データ分析
  • がん
  • 感染症
  • 血液疾患
  • その他

第8章 脂質ナノ粒子原料の世界市場分析：最終用途別

  • 概要：最終用途別
  • 最終用途別過去・予測データ分析
  • 製薬バイオテクノロジー企業
  • 学術研究機関
  • その他

第9章 脂質ナノ粒子原料の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東アフリカ売上分析
    • 概要、実績と予測
    • 中東アフリカ：セグメント別
    • 中東アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第10章 脂質ナノ粒子原料企業の競合情勢

  • 脂質ナノ粒子原料市場競争
  • パートナーシップ/提携/合意
  • 合併と買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Merck KGaA
  • Darmstadt
  • Germany
  • Echelon Biosciences Inc.
  • BroadPharm
  • Avanti Research（Formerly Avanti Polar Lipids）
  • Tebubio
  • CordenPharma International
  • Creative Biolabs
  • Biopharma PEG Scientific Inc.
  • NOF America Corporation
  • Polysciences Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Application (USD MN)
  • Therapeutics Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Ionizable lipids Market Sales By Geography (USD MN)
  • Reagents Market Sales By Geography (USD MN)
  • Other Raw Materials Market Sales By Geography (USD MN)
  • Analysis By Disease Indication (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Blood Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Pharmaceutical Biotechnology Companies Market Sales By Geography (USD MN)
  • Academic Research Institutes Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Lipid Nanoparticle Raw Materials Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Lipid Nanoparticle Raw Materials Report
  • Market Research Process
  • Market Research Methodology
  • Global Lipid Nanoparticle Raw Materials Market Size, By Regions (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Disease Indication
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Regions
  • Value Chain Analysis
  • Global Market Analysis By Application (USD MN)
  • Therapeutics Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Ionizable lipids Market Sales By Geography (USD MN)
  • Reagents Market Sales By Geography (USD MN)
  • Other Raw Materials Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease Indication (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Blood Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Pharmaceutical Biotechnology Companies Market Sales By Geography (USD MN)
  • Academic Research Institutes Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112114586

Global Lipid Nanoparticle Raw Materials Market size is anticipated to grow from USD 258.47 Million in 2024 to USD 430.79 Million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 5.84% during the forecast period of 2026 to 2033.

The lipid nanoparticle raw materials market is poised for significant growth as the demand for advanced drug delivery systems continues to rise in the pharmaceutical and biotechnology industries. Lipid nanoparticles (LNPs) have emerged as a promising technology for delivering therapeutic agents, including mRNA vaccines and gene therapies, due to their ability to encapsulate and protect sensitive molecules while facilitating cellular uptake. As the global focus on innovative drug delivery solutions intensifies, the lipid nanoparticle raw materials market is expected to expand significantly, driven by the need for high-quality materials that enhance the efficacy and safety of pharmaceutical products.

Moreover, the increasing emphasis on personalized medicine and targeted therapies is influencing the lipid nanoparticle raw materials market, as researchers seek to develop tailored drug delivery systems that meet the specific needs of patients. The versatility of lipid nanoparticles allows for the incorporation of various therapeutic agents, making them suitable for a wide range of applications, from oncology to rare diseases. As the market evolves, the focus on innovation and customization will drive growth in the lipid nanoparticle raw materials sector.

Additionally, the rise of e-commerce and digital marketing is transforming the lipid nanoparticle raw materials market, providing manufacturers with new avenues to reach consumers and researchers. Online platforms enable suppliers to showcase their products and connect with a global audience, facilitating the growth of the market. As the demand for lipid nanoparticle raw materials continues to expand, manufacturers that prioritize quality, innovation, and customer engagement will be well-positioned for success. With a focus on efficacy, safety, and customization, the future of the lipid nanoparticle raw materials market looks promising, paving the way for enhanced drug delivery solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Application

  • Therapeutics
  • Research

By Product

  • Ionizable lipids
  • Reagents
  • Other Raw Materials

By Disease Indication

  • Cancer
  • Infectious Diseases
  • Blood Diseases
  • Others

By End-Use

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others
  • COMPANIES PROFILED
  • Merck KGaA
  • Darmstadt
  • Germany
  • Echelon Biosciences Inc.
  • BroadPharm
  • Avanti Research (Formerly Avanti Polar Lipids)
  • Tebubio
  • CordenPharma International
  • Creative Biolabs
  • Biopharma PEG Scientific Inc.
  • NOF America Corporation
  • Polysciences Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. LIPID NANOPARTICLE RAW MATERIALS – INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Application
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Disease Indication
    • 3.7.4 Market Attractiveness Analysis By End-Use
    • 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET ANALYSIS BY APPLICATION

  • 5.1. Overview By Application
  • 5.2. Historical and Forecast Data Analysis By Application
  • 5.3. Therapeutics Historic and Forecast Sales By Regions
  • 5.4. Research Historic and Forecast Sales By Regions

6. GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET ANALYSIS BY PRODUCT

  • 6.1. Overview By Product
  • 6.2. Historical and Forecast Data Analysis By Product
  • 6.3. Ionizable lipids Historic and Forecast Sales By Regions
  • 6.4. Reagents Historic and Forecast Sales By Regions
  • 6.5. Other Raw Materials Historic and Forecast Sales By Regions

7. GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET ANALYSIS BY DISEASE INDICATION

  • 7.1. Overview By Disease Indication
  • 7.2. Historical and Forecast Data Analysis By Disease Indication
  • 7.3. Cancer Historic and Forecast Sales By Regions
  • 7.4. Infectious Diseases Historic and Forecast Sales By Regions
  • 7.5. Blood Diseases Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-Use
  • 8.2. Historical and Forecast Data Analysis By End-Use
  • 8.3. Pharmaceutical Biotechnology Companies Historic and Forecast Sales By Regions
  • 8.4. Academic Research Institutes Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East Africa By Segment Sales Analysis
    • 9.7.3 Middle East Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE LIPID NANOPARTICLE RAW MATERIALS COMPANIES

  • 10.1. Lipid Nanoparticle Raw Materials Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF LIPID NANOPARTICLE RAW MATERIALS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Merck KGaA
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Darmstadt
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Germany
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Echelon Biosciences Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. BroadPharm
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Avanti Research (Formerly Avanti Polar Lipids)
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Tebubio
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. CordenPharma International
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Creative Biolabs
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Biopharma PEG Scientific Inc.
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. NOF America Corporation
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Polysciences Inc
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies